## 

## 

## 

|||||||Page|
|---|---|---|---|---|---|---|
|Trustees'<br>annual<br>report (incorporating|||the|director's|report)||
|Independent<br>examiner's<br>report to the|||trustees||||
|Statement<br>of financial|activities|(including||income and|||
|expenditure<br>account)|||||||
|Statement<br>of financial|position||||||
|Notes to the financial|statements||||||





## 

## 

## 

|Reference|and administrative|and administrative|and administrative|and administrative|details||||
|---|---|---|---|---|---|---|---|---|
|Registered||charity|name||The Livewell<br>Foundation||||
|Charity registration|||number||1172401||||
|Company|registration|||number|10524700||||
|Principal office and|||registered||Local Care Centre||||
|office|||||200 Mount Gould Road||||
||||||Mount Gould||||
||||||Plymouth||||
||||||United<br>Kingdom||||
||||||PL4 7PY||||
|The trustees|||||||||
||||||Amie Carr|(Appointed|29 September|2022)|
||||||Juliet Simmons|(Appointed|29 September|2022)|
||||||Oliver Jackman|(Appointed|29 September|2022)|
||||||Craig Hampton-Stone|(Resigned|24 May 2022)||
||||||Geoffrey Baines||||
||||||Jill Davies (Vice chair)||||
||||||Nakul Puri(Treasurer)||||
||||||Rachel Marshall||||
||||||Kay O'Shaughnessy|(Appointed|29 September|2022)|
||||||Morris Watts|(Appointed|1 January 2023)||
||||||Christopher<br>Davies (Chairman)|(Appointed|29 September|2022)|
|Independent||examiner|||A Croney||||
||||||Westcotts (SW) LLP||||
||||||Plym House||||
||||||3 Longbridge<br>Road||||
||||||Marsh<br>Mills||||
||||||Plymouth||||
||||||PL6 8LT||||



## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

||||||||Restated|
|---|---|---|---|---|---|---|---|
||||||2023||2022|
|||||Unrestricted|Restricted|||
|||||funds|funds|Total funds|Total funds|
||||Note|8|8|2|2|
|Income and endowments||||||||
|Donations<br>and|legacies||5|112,556||112,556|117,554|
|Total income||||112,556||112,556|117,554|
|Expenditure||||||||
|Expenditure<br>on|charitable|activities|6,7|120,264|4,455|124,719|54,014|
|Total expenditure||||120,264|4,455|124,719|54,014|
|Net movement|in funds|||(7,708)|(4,455)|(12,163)|63,540|
|Reconciliation|offunds|||||||
|Total funds brought<br>forward||||272,656|220,579|493,235|429,695|
|Total funds carried forward||||264,948|216,124|481,072|493,235|





## 

## 

|3f March 2023||||||
|---|---|---|---|---|---|
||||||Restated|
|||||2023|2022|
||||Note|2||
|Current assets||||||
|Cash at bank and|in|hand||498,076|508,641|
|Net current assets||||498,076|508,641|
|Total assets less|current liabilities|||498,076|508,641|
|Creditors: amounts||falling due after more than one year|13|17,004|15,406|
|Net assets||||481,072|493,235|
|Funds ofthe charity||||||
|Restricted<br>funds||||216,124|220,579|
|Unrestricted<br>funds||||264,948|272,656|
|Total charity funds|||14|481,072|493,235|





## 

## 

## 

||||||Restated|
|---|---|---|---|---|---|
|||||2023|2022|
|||||2||
|Cash flows from operating||activities||||
|Net income||||(12,163)|63,540|
|Changesin:||||||
|Trade and other debtors|||||753|
|Trade and other creditors||||1,598|15,406|
|Net cash from operating|activities|||(10,565)|79,699|
|Net increase/(decrease)|in|cash and cash|equivalents|(10,565)|79,699|
|Cash and cash equivalents||at beginning|ofyear|508,641|428,942|
|Cash and cash equivalents||at end ofyear||498,076|508,641|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

|Donations<br>and grants recei|vable||||
|---|---|---|---|---|
|||||Restated|
||Unrestricted|Total Funds|Unrestricted|Total Funds|
||Funds|2023|Funds|2022|
||2|2|2||
|Donations|12,556|12,556|17,554|17,554|
|Grants receivable|100,000|100,000|100,000|100,000|
||112,556|112,556|117,554|117,554|



## 

|Expenditure|on c|haritable|activities by fund type||||
|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2023|
|||||||2|
|General funds||||111,846||111,846|
|Mount Gould|Legacy||||3,815|3,815|
|Plym Neuro|Fund|||8,418||8,418|
|Westbourne|Legacy||||640|640|
|||||120,264|4,455|124,719|
|||||||Restated|
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2022|
||||||2|6|
|General funds||||32,305||32,305|
|Mount Gould|Legacy||||14,356|14,356|
|Plym Neuro|Fund|||1,563||1,563|
|Tavistock General||Fund||5,357||5,357|
|Westbourne|Legacy||||433|433|
|||||39,225|14,789|54,014|
|Expenditure|on charitable||activities by activity type||||
|||||Activities||Restated|
||||Grant funding|undertaken|Total funds|Total fund|
||||of activities|directly|2023|2022|
||||||2|2|
|General funds|||108,171|3,675|111,846|32,305|
|Mount Gould|Legacy|||3,815|3,815|14,356|
|Plym Neuro|Fund|||8,418|8,418|1,563|
|Tavistock General||Fund||||5,357|
|Westbourne|Legacy|||640|640|433|
||||108,171|16,548|124,719|54,014|



## 



## 

## 

## 

## 

## 

|8.|Analysis of|sup|port cos|ts|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|||||||Staff|& patient||||
||||||Staff|Equipment|welfare||||
||||development|||grants|amenities|Support costs|Total|2023|
|||||||||2||2|
||General funds||||627|908|208|1,932||3,675|
||Mount Gould <br>Plym Neuro|Legacy<br> Fund|||854|2,331<br>6,662|215|1,269<br>902||3,815<br>8,418|
||Westbourne|Legacy||||||640||640|
||||||1,481|9,901|423|4,743|16,548||
||||||||Staff &||||
||||||||patient||||
||||||Staff|Equipment|welfare||Restated||
||||development|||grants|amenities|Support costs|Total|2022|
|||||||2||||2|
||General funds|||||27,493|1,242|3,570|32,305||
||Mount Gould Legacy<br>Plym Neuro Fund<br>Tavistock General<br>Fund|||||15,002<br>671<br>5,357|225<br>1,100|(871)<br>(208)|14,356<br>1,563<br>5,357||
||Westbourne|Legacy||||||433||433|
|||||||48,523|2,567|2,924|54,014||
|9.|Independent|examination||fees|||||||
|||||||||2023||2022|
|||||||||2|||
||Fees payable to||the independent||examiner|for:|||||
||Independent|examination||ofthe|financial statements|||2,100||1,938|
||Other financial services|||||||3,225||3,000|
|||||||||5,325||4,938|



## 

## 

## 




## 

## 

## 

|Unrestricted|funds|funds|||||||
|---|---|---|---|---|---|---|---|---|
||||At 1 April 22|Income|Expenditure|Transfers|At|31 Mar 23|
||||2|2|||||
|Designated|Funds||||||||
|Plym Neuro|Fund||35,129|1,796|(8,418)|—||28,507|
||||35,129|1,796|(8,418)|—||28,507|
|General Funds|||||||||
|General funds|||237,527|110,760|(111,846)|—||236,441|
||||272,656|112,556|(120,264)|—||264,948|
|||||||||Restated|
||||At 1 April 21|Income|Expenditure|Transfers|At|31 Mar 22|
||||2|||||2|
|Designated|Funds||||||||
|Plym Neuro Fund<br>Tavistock General||Fund|20,513<br>4,596|6,943|(1,563)<br>(5,357)|9,236<br>761||35,129|
||||25,109|6,943|(6,920)|9,997||35,129|
|General Funds|||||||||
|General funds|||158,915|110,611|(32,305)|306||237,527|
||||184,024|117,554|(39,225)|10,303||272,656|





## 

## 

## 

## 

## 

## 

|||At|1 April 22|Income|Expenditure|Transfers|At 31 Mar 23|
|---|---|---|---|---|---|---|---|
|||||2||2|2|
|Mount Gould|Legacy||147,477||(3,815)||143,662|
|Westbourne|Legacy||73,102||(640)||72,462|
||||220,579||(4,455)||216,124|
||||||||Restated|
|||At|1 April 21|Income|Expenditure|Transfers|At 31 Mar 22|
||||||||2|
|Mount Gould|Legacy||163,838||(14,356)|(2,005)|147,477|
|Plym Neuro|Legacy||9,098|||(9,098)||
|Westbourne|Legacy||73,535||(433)||73,102|
|Othertunds|||(800)|||800||
||||245,671||(14,789)|(10,303)|220,579|



## 

|Analysis of net as|sets between funds||||
|---|---|---|---|---|
|||Unrestricted|Restricted|Total Funds|
|||Funds|Funds|2023|
|||2||2|
|Current assets||281,952|216,124|498,076|
|Creditors less than|1 year|(17,004)||(17,004)|
|Net assets||264,948|216,124|481,072|
|||Restated|Restated||
|||Unrestricted|Restricted|Total Funds|
|||Funds|Funds|2022|
|||2|||
|Current assets||277,452|231,189|508,641|
|Creditors less than|1 year|(4,796)|(10,610)|(15,406)|
|Net assets||272,656|220,579|493,235|





## 

## 

## 

## 

## 

## 

|14.|Reconciliation<br>o|fnet|mo|vement<br>in fu|nds to net c|ash flow from o|perating<br>activit|ies|
|---|---|---|---|---|---|---|---|---|
||||||||2023|2022|
||||||||2||
||Net income/expenditure||||||(12,163)|63,540|
||Trade and other debtors|||||||753|
||Trade and other creditors||||||1,598|15,406|
||Net cash provided|by/used||in operating|activities||(10,565)|79,699|
|15.|Analysis ofcash|and|cash equivalents||||||
||||||||2023|2022|
||||||||2|2|
||Cash and cash equivalents||||||498,076|508,641|
|16.|Analysis ofchanges||in net debt||||||
|||||||At Mar 22|Cash flows|At Mar 23|
|||||||||2|
||Cash at bank and|in hand||||508,641|(10,565)|498,076|



## 

## 

